Account
Inquiry
QSC Tirzepatide is a novel peptide compound developed for research into metabolic disorders including obesity and type 2 diabetes. This GLP-1 receptor agonist demonstrates promising results in clinical studies for weight management applications.
Our pharmaceutical-grade QSC Tirzepatide is manufactured under strict quality control standards, delivering consistent purity and performance for research applications. The product is supplied in lyophilized form for optimal stability.
Key characteristics of our QSC Tirzepatide include triple agonist activity targeting glucagon receptors (GCGR), glucose-dependent insulinotropic polypeptide receptors (GIPR), and glucagon-like peptide-1 receptors (GLP-1R). This multi-target mechanism shows enhanced efficacy in metabolic regulation studies compared to single-agonist compounds.
For research use only. Not for human consumption. Proper storage at -20°C or below is required to maintain product integrity. Researchers should follow all laboratory safety protocols when handling this material.
The product is available in various concentrations to accommodate different research requirements, with customizable packaging options available for bulk orders. Our manufacturing facility maintains full documentation and quality control records for all batches.
